HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Barbara P Wallner Selected Research

PT-100 dipeptide

9/2003Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Barbara P Wallner Research Topics

Disease

2Neoplasms (Cancer)
02/2012 - 08/2004
1Sarcoma (Soft Tissue Sarcoma)
02/2012
1Carcinoma (Carcinomatosis)
08/2004
1Fibrosarcoma
08/2004
1Lymphoma (Lymphomas)
08/2004
1Melanoma (Melanoma, Malignant)
08/2004
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2004
1Mastocytoma
08/2004
1Neutropenia
09/2003
1Anemia
09/2003

Drug/Important Bio-Agent (IBA)

2talabostatIBA
08/2004 - 09/2003
1isophosphamide mustard (IPAM)IBA
02/2012
1Docetaxel (Taxotere)FDA Link
02/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2012
1ChemokinesIBA
08/2004
1Rituximab (Mabthera)FDA Link
08/2004
1Trastuzumab (Herceptin)FDA Link
08/2004
1Proteins (Proteins, Gene)FDA Link
08/2004
1CytokinesIBA
08/2004
1PT-100 dipeptideIBA
09/2003

Therapy/Procedure

2Oral Administration
02/2012 - 08/2004
1Intravenous Administration
02/2012